ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network

ApiLabs logo

ApiLabs logo

GENEVA, Sept. 15, 2022 (GLOBE NEWSWIRE) — ApiLabs, an R&D company developing innovative, affordable medical technologies to maximize healthcare access for patients in all world regions, has launched its ApiLabs Field Research Network (AFRN).

AFRN gathers qualitative and quantitative data from real-world settings through ground level investigations, particularly in low- and middle-income countries. Resulting information helps ApiLabs engineers develop medical devices for all global markets, which its sister company ApiJect Systems then helps commercialize with pharmaceutical partners.

“Our Field Research Network is vital in the development of medical devices that truly meet the needs of local populations anywhere in the world,” said Edward Kelley, PhD, ApiLabs’ Chief Global Health Officer. “Historically, medical devices for global markets have been designed in laboratories with far too little interaction and feedback from field healthcare personnel and their patients.”

ApiLabs launched AFRN in collaboration with two highly experienced healthcare support organizations. Butterfly Works recently completed its first AFRN project in Kenya’s Kwale county, researching intradermal injections and injectable contraceptives that give women greater control of their reproductive health.

A team from Dalberg Design (India) recently commenced AFRN research in two Indian states, Bihar and Karnataka. ApiLabs will gradually expand AFRN to include additional organizations in other world regions, ensuring universal device viability.

Each team assesses needs, behaviors, attitudes, preferences, and aspirations of patients and health workers; obtains qualified feedback from end users on a new device from concept through prototypes; and identifies potential obstacles to effective distribution and use. Resulting data guides ApiLabs engineers in developing devices for ApiJect, whose platform combines Blow-Fill-Seal pharmaceutical packaging with attachable components, such as needle hubs.

ApiLabs’ Co-founder and Head of R&D is Marc Koska, OBE, creator of the K1 auto-disable syringe. “I have always believed creating medical devices starts with patients and their environment,” says Mr. Koska. “At ApiLabs, our design process first determines local healthcare professionals’ and healthcare systems’ needs and conditions, so every device is suitable for every market.”

Merel van der Woude, Creative Director at Butterfly Works, confirmed this approach: “After two intense weeks of observations and speaking with more 100 healthcare providers and their clients, we had a much deeper understanding of the needs for safety, affordability, comfort and accessibility. The results are described in context of specific healthcare stories that allow us to see a problem from different perspectives.”

Prerak Mehta, Director at Dalberg Design, highlighted AFRN’s strategy: “Today’s medical products should satisfy people’s needs, align with their preferences, take socio-economic realities into consideration and meet their aspirations. That is when sustainable product innovation becomes a widespread success.”

Additional senior members at ApiLabs include Paul Rutter, MD, and Jane Chen, MPA-MBA.

Learn about ApiLabs’ Global Health Team at apijectglobalinitiative.comRead their free newsletter globe.substack.com.

Visit Butterfly Works at www.butterflyworks.org.

Dalberg Design is at www.dalbergdesign.com.

Contact

Kate Scott, kscott@apiject.com

Related Files

Press Release – ApiLabs Research Field Network – final.pdf

Related Images

Image 1: ApiLabs logo

Logo of ApiLabs, LLC, sister R&D company to ApiJect Systems.

This content was issued through the press release distribution service at Newswire.com.

Attachment

Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022

September 15, 2022

Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system, anytime and anywhere, to enhance diagnostic confidence for physicians and provide peace of mind for expectant mothers

Amsterdam, the Netherlands and London, United Kingdom – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the upcoming addition of  the FetView cloud-based fetal ultrasound image sharing and reporting software for obstetrics/gynecology (OB/GYN). As a vendor-neutral cloud-based platform for ultrasound images, FetView will utilize the ultrasound image data to convey fetal growth projections and provide a user-friendly platform for physician to physician and physician to patient communication.

Philips Fetview is an integrated solution that combines fetal ultrasound imaging with enhanced reporting and easy access to an expectant mother’s medical data and fetal images. All results are securely stored and displayed in real time. With this upcoming addition of FetView into Philips’ advanced portfolio for Ultrasound in OB/GYN – which includes Lumify Handheld Ultrasound, diagnostic ultrasound systems EPIQ, Affiniti and mobile app Pregnancy+ – pregnant women and their care teams will have access to a comprehensive overview of how a pregnancy is progressing to help provide peace of mind to patients and enhance diagnostic confidence for clinicians.

With OB/GYN ultrasounds performed in different clinical settings, immediate remote access to ultrasound images and medical histories for collaborative decision-making and easy sharing of images with patients is a challenge. Philips FetView will allow physicians to view, analyze, and annotate ultrasound images in real time via a cloud-based browser-accessible platform for secure image sharing, to help improve quality access to care, reduce patient mobility in case of high-risk pregnancies or post-surgery conditions, and reduce the need to rescan patients. By enabling full digitalization of OB/GYN workflows and patient management, Philips FetView will help drive greater departmental efficiency, reduce costs, and provide a better patient and staff experience.

“I see multiple patients from many areas in my daily practice, and the implementation of FetView has meant a turbo boost in productivity for my practice,” said Prof. Alexander Scharf,  Managing Director, MVZ PraenatGyn, Mainz, Germany. “The flexibility of the software is seamlessly integrated into my existing workflows and everything I need to access in the reporting is just one click away. FetView has also had a very positive impact on my patients, who have showed great enthusiasm for this program. The digital sharing of ultrasound images taken as part of prenatal care in accordance with data protection regulations and shared via a secure portal, help provide added peace of mind which is so important to expectant mothers.”

“The cloud-based reporting and image sharing capabilities of Philips FetView enhance remote communication between physicians and patients,” said Matthijs Groot Wassink, General Manger, OB/GYN Ultrasound at Philips. “By digitizing the workflow, we are taking ultrasound to the next level, delivering smart ultrasound documentation to any OB/GYN practice. The digital reporting and image sharing, and fully customizable design are hugely helpful for physicians, helping to drive efficiency and cost savings with increasing patient satisfaction in their daily practice.”

Philips FetView’s vendor-neutral software will retrieve images and measurement data via a secure encrypted DICOM interface and display them in a structured layout where care team members can easily add new information and data in line with their individual specialisms and produce easy-to-read growth curves. The application also streamlines the generation of reports in PDF format to be uploaded to electronic patient records and shared online with other clinicians and individual patients.

Philips FetView will be featured with additional Philips OB/GYN solutions helping to drive earlier and more definitive diagnoses being showcased at this year’s International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress (September 16 – 18, 2022, London, U.K.). Philips is also hosting a Satellite Symposium [1] on September 16 at ISUOG 2022 (Hall 3, 12:30 – 13:30 BST), where international thought leaders, including Prof. Scharf, will discuss the future of obstetric and gynecological care and fetal medicine.

[1] Available for 12 months after the event on the ISUOG on-demand portal

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail : kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Alchip Technologies Sets Record First Half Revenue and Net Income

Q2’ 22 Revenue Sets Record

Taipei, Taiwan, Sept. 15, 2022 (GLOBE NEWSWIRE) — Alchip Technologies sets revenue and net income records for the first half of 2022 and record revenue for Q2 2022.

First half revenue reached a record $194.6 million, while net income for the same period achieved a record $30.5 million.

Second quarter 2022 revenue notched another record of $101.1 million, up 3.9 percent over the $97.4 million from Q2 2021 and up 8.2 percent over Q1 2022 revenue of $93.5 million. At the same time, second quarter net income reached $14.5 million, up 4.3 percent over Q2 2021 net income of $13.9 million, but fell short of Q1 2022 net income of $16 million by 9.5 percent.  Second quarter operating income was reported at $19.3 million, a 10.7 percent increase over Q2 2021 operating income of $17.5 million, but down slightly from Q1 2022 results of $19.6 million.  Earnings per share for Q2 2022 were NTD 6.0.

Revenue for Q2 came in mildly lower than expected, due to ABF substrate supply constraints. Design demand, however, remained robust with no demand weakening in sight amid a slowing macro-environment.

Laying out the company’s view going forward, Alchip President and CEO, Johnny Shen announced that strong mass production demand remains unchanged and that the company would maintain its hallmark advanced technology leadership.

“We’re seeing our highest business inquiries for advanced technology 7nm, 6nm, 5nm and 4nm opportunities.  This is on top of the fact that our announcement of accepting 3nm design created a great deal of interest in the high-performance computing and AI communities.  In addition, we are experiencing significant market penetration in a number of automotive applications,” he said.

Alchip is traded on the Taiwan stock exchange.  The company is extremely well respected in North America, Japan, Israel, Taiwan, and China for its high-performance ASIC design methodology, flexible business model, best-in-class IP portfolio and advanced packaging technology expertise.

For a more information on Alchip, go to www.alchip.com

 

About Alchip

Alchip Technologies Ltd., founded in 2003 and headquartered in Taipei, Taiwan, is a leading global provider of silicon and design and production services for system companies developing complex and high-volume ASICs and SoCs. The company provides faster time-to-market and cost-effective solutions for SoC design at mainstream and advanced, including 7nm, 6nm, 5nm and 4nm processes. Alchip has built its reputation as a high-performance ASIC leader through its advanced 2.5D/3D package services, CoWoS/chiplet design and manufacturing experience. Customers include global leaders in AI, HPC/supercomputer, mobile phones, entertainment device, networking equipment and other electronic product categories. Alchip is listed on the Taiwan Stock Exchange (TWSE: 3661) and is a TSMC-certified Value Chain Aggregator.

Attachment

Charles Byers
Alchip Technologies
+ (408) 310-9244
chuck_byers@alchip.com

Material Acquires Srijan Technologies to Strengthen Technology and Global Delivery Capabilities

Acquisition Catalyzes Science and Systems Approach

Material Acquires Srijan Technologies

Leading customer experience transformation company, Material, has acquired Srijan Technologies, a renowned global digital engineering firm.

LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) — Leading customer experience transformation company, Material, today announced that it has acquired Srijan Technologies, a renowned global digital engineering firm with offices across India, APAC, Europe, and the US.

Material’s unique approach to shaping customer experience powerfully combines strategy, insights, design and technology, using the company’s “Science and Systems” approach. The addition of Srijan enables Material to further strengthen this approach by offering deeper abilities in digital experience and data platforms, cloud engineering, and modern data engineering, broadening Material’s technology expertise and its capability to build a wide range of transformative digital experiences.

Over the past two decades, Srijan has built a reputation for solving complex technology problems for some of the world’s leading brands, made possible by their deep technology expertise and strategic partnerships with top tier technology partners. Srijan is one of the world’s leading Drupal service providers, with over 600 digital and data engineers in India. Srijan’s founder and CEO Rahul Dewan serves on the board of the Drupal Association. Srijan was named winner of the Acquia Top Growth Partner Award for 2021, has partnerships with Amazon Web Services (AWS) and Google Apigee, a services relationship with VMWare, and holds partnerships with several other leading technology platforms powering digital experience solutions.

The company brings advanced engineering capabilities and best-in-class agile software development practices to Global 2000 clients across Media, Financial Services, CPG, Telecom, and Technology. For 6 years in a row Srijan has been recognized as a Great Places To Work™ and has also been recognized among the Top 50 Tech Companies in India by Deloitte.

“With this acquisition, we deepen our capability footprint in digital platforms, cloud, API, and data engineering to meet our clients’ evolving needs with an integrated and distributed delivery model. What really attracted us to Srijan is a shared passion for client success and their expertise in solving truly complex technology problems. I could not be more excited as we add world class digital engineering expertise to our clients’ increasing technology needs. This also gives us a stronger global presence which many of our clients have been asking us for,” said Material’s CEO Bill Kanarick. “This acquisition deepens and extends our Science and Systems proposition and enables us to help clients transform their customer relationships given the digitally driven customer-centric imperative they face,” he added.

Rahul Dewan, Founder and CEO of Srijan, said, “Over the past twenty years, we have built something truly special. As part of the continued growth for our people, and to give greater expression to our culture, values and engineering processes that we proudly call “the Srijan way”, it was important to us to partner with a firm that brings deep and complementary expertise and relationships with blue-chip clients, while having a strong, values-based culture. In Material, we have found all of that. Over the past few months, as we have collaborated on multiple client engagements, it has been exciting and gratifying to see the ease with which our teams have worked together to pursue truly complex experience transformation challenges.”

Mike Sullivan, President and CEO of Acquia, said, “We’re excited to see Srijan, Acquia’s Top Growth Partner for 2021, join forces with Material. Srijan has consistently been a top contributor to Drupal development and applied that expertise to creating transformative digital journeys. Acquia looks forward to expanding our work with the combined organization to bring together content and data to create total experiences for clients.”

With this acquisition, Material will have a global headcount of 2000+ people. Added Kanarick, “This acquisition marks an important milestone in our journey as we build a highly differentiated customer experience transformation partner for our clients.”

Material is a portfolio company of Tailwind Capital.

About Material
Material is a global strategy, insights, design, and technology partner to companies striving for true customer centricity and ongoing relevance in a digital first, customer-led world. By leveraging proprietary, science-based tools that enable human understanding, we inform and create customer-centric business models and experiences + deploy measurement systems – to build transformational relationships between businesses and the people they serve. Learn more at materialplus.io.

About Srijan, a Material Company
Srijan is a global engineering firm that builds transformative digital paths to better futures for Fortune 500 enterprises to nonprofits all over the world. Srijan brings advanced engineering capabilities and agile practices to some of the biggest names across FMCG, Aviation, Telecom, Technology, and others. We help businesses embrace the digital future with cloud, data, API and platform centric technologies and adapt to changing business models and market demands. Srijan leads in Drupal with 350+ Drupal engineers, 80+ Acquia certifications. Srijan is also a Drupal Enterprise Partner & Diamond Certified Contributor. Learn more at srijan.net.

About Tailwind Capital
Tailwind Capital is a middle market private equity firm focused on services companies in three core subsectors – IT Services, Infrastructure Services, and Supply Chain. Tailwind partners with management teams to Accelerate Change, our operationally intensive approach to value creation through investments in Talent, Technology and Transformative M&A. Since inception, Tailwind has invested approximately $4 billion in over 220 acquisitions, including over 50 platform companies and over 170 add-on acquisitions.

Media Contact:
Melanie Capruso
DiGennaro Communications
Melanie.capruso@Digennaro-usa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/33d44c73-d3f1-4e2b-afb0-0151bb11e472

300 flood warning sirens being upgraded – DID

PUTRAJAYA, Sept 15 (Bernama) — About 300 of the 500 flood warning sirens nationwide are being upgraded to enable warning signals to be delivered more effectively to local residents, said Department of Irrigation and Drainage (DID) director-general Datuk Ir Dr Md Nasir Md Noh.

He said the warning sirens would have a loud and different sound than police or ambulance sirens and would be followed by announcements to alert residents that there would be flooding in their area.

“We are increasing the siren volume and will equip the system with public announcements. Before this, no announcement was made. These sirens are installed in critical areas throughout the country,” he said, adding that the system’s test run had been conducted with residents in certain locations.

Md Nasir said this during the Disaster Management Committee Secretariat and Technical Agencies-Media programme at SMART headquarters in Pulau Meranti near here today.

On Monday, Prime Minister Datuk Seri Ismail Sabri Yaakob said the Central Disaster Management Committee meeting agreed that the early warning sirens should be different from other sirens such as ambulances and police patrol cars so as to avoid confusion.

Meanwhile, Malaysian Meteorological Department (MetMalaysia) director-general Muhammad Helmi Abdullah said the department would install five more weather radars by next year, taking the total number of radars nationwide to 19.

“With these radars, it can further strengthen the weather monitoring operation… we will be able to issue rain or thunderstorm warnings more quickly,” he said.

The northeast monsoon season will bring continued heavy rains that will lead to major flooding, especially in the east coast states.

Heavy rains are expected in Kelantan, Terengganu and Pahang from November to December 2022, while Johor, Sabah and Sarawak will face the monsoon from December 2022 to January 2023.

Source: BERNAMA News Agency

Tessa recognised in “Most Promising Off-the-Shelf Therapies” category at ACGTEA 2022

KUALA LUMPUR, Sept 15 (Bernama) — Tessa Therapeutics Ltd (Tessa), a clinical-stage cell therapy company, has announced that TT11X, the company’s allogeneic “off-the-shelf” CD30.CAR EBVST cell therapy, has been recognised in the “Most Promising Off-the-Shelf Therapies” category at the Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022.

According to a statement, the ACGTEA 2022 Awards were held in conjunction with the 6th Cell & Gene Therapy World Asia 2022.

“We are very excited to be recognised among the innovators in developing ‘off-the-shelf’ cell therapy technologies and greatly appreciate the ACGTEA 2022 award,” said Chief Medical Officer and Chief Scientific Officer of Tessa Therapeutics, Dr Ivan Horak.

“Allogeneic cell therapy technology has the potential to transform the accessibility and affordability of CAR-T, but toxicity concerns remain a key obstacle.

“Data from our ongoing Phase 1 trial of TT11X suggest that our CD30.CAR EBVST platform has the potential to overcome these toxicity challenges, including GVHD, while also eliciting promising signals of efficacy.”

TT11X is based on Tessa’s proprietary CD30.CAR-modified Epstein-Barr virus-specific T-cell (EBVST) platform.

This technology was developed following decades-long research by the company’s Scientific Co-Founder, Malcolm Brenner, M.D., Ph.D., and researchers at Baylor College of Medicine, into the unique properties of virus specific T-cells (VSTs).

These highly specialised T cells have the ability to recognise and kill infected cells while activating other parts of the immune system for a coordinated response.

Allogeneic VSTs without any form of genetic modification have demonstrated a strong safety profile and efficacy in early trials with minimal risk of graft rejection and Graft vs Host Disease (GVHD).

Source: BERNAMA News Agency

PM Ismail Sabri pays homage to Queen Elizabeth II, signs condolence book

KUALA LUMPUR, Sept 15 (Bernama) — Prime Minister Datuk Seri Ismail Sabri Yaakob today visited the British High Commissioner’s Residence here, offering condolences over the passing of Britain’s Queen Elizabeth II.

Ismail Sabri also signed the condolence book as a mark of respect for the Queen who died on Sept 8 at the age of 96.

Earlier, on his arrival at 3.55 pm, British High Commissioner to Malaysia, Charles Hay and Deputy Foreign Minister Datuk Kamarudin Jaffar welcomed the Prime Minister.

Ismail Sabri spent over 30 minutes at the High Commissioner’s Residence.

The Queen was the longest reigning monarch in British history and the second-longest reigning monarch after King Louis XIV of France.

Meanwhile, Hay said he was touched by the message of condolence from Ismail Sabri as well as the outpouring of affection and respect by Malaysians from all walks of life. 

“It is heartening to receive such support in Malaysia as the United Kingdom mourns the passing of the Queen,” he said.

According to media reports, the Queen’s body is now in London, where it will lie in state until the state funeral service at Westminster Abbey on Sept 19.

Her Majesty will be buried alongside her husband, Prince Philip.

Source: BERNAMA News Agency